MARKOLINES PAVEMENT TECHNOLOGIES
|
|
| BOM : 543364     NSE : MARKOLINES     | |
| LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : None or < 25% |
Jul 01,2026 |
|
Price(EOD): ₹ 182.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Engineering - Construction |
| MCap: ₹ 405.71 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MARKOLINES PAVEMENT TECHNOLOGIES | 5.5% | 9% | 9.6% |
| LARSEN & TOUBRO | -2.2% | 2.1% | 15% |
| RAIL VIKAS NIGAM | -1% | -1.6% | -40.8% |
| IRB INFRASTRUCTURE DEVELOPERS | NA | -2.5% | -12.2% |
| KALPATARU PROJECTS INTERNATIONAL | -2.8% | 4.5% | 16% |
| CEMINDIA PROJECTS | 11.9% | 27% | 60% |
| TECHNO ELECTRIC & ENGINEERING COMPANY | 0.8% | 2.7% | -31% |
| ENGINEERS INDIA | -6.3% | 5.8% | 2.7% |
| IRCON INTERNATIONAL | -0.1% | 1% | -34.7% |
FUNDAMENTAL ANALYSIS OF MARKOLINES PAVEMENT TECHNOLOGIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF MARKOLINES PAVEMENT TECHNOLOGIES
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
15.91
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 25.51 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 2.38
P/B Calculated based on Book Value of Rs 170.24 Cr
[Latest Year - Mar2025 - Consolidated Results ] 1.16
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 348.49 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
62% 87% 50% |
SHARE PRICE MOMENTUM OF MARKOLINES PAVEMENT TECHNOLOGIES
MARKOLINES PAVEMENT TECHNOLOGIES vs SENSEX
DEBT OF MARKOLINES PAVEMENT TECHNOLOGIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.37 0.58 0.36 0.44 |
0.37 0.58 0.36 0.44 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF MARKOLINES PAVEMENT TECHNOLOGIES
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF MARKOLINES PAVEMENT TECHNOLOGIES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
13.12% 59.53% 77% 65.01% |
-13.47% -20.49% -11.56% -7.2% |
| QtrlyTrend |
0 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
MARKOLINES PAVEMENT TECHNOLOGIES related INDICES
You may also like the below Video Courses
FAQ about MARKOLINES PAVEMENT TECHNOLOGIES
Is MARKOLINES PAVEMENT TECHNOLOGIES good for long term investment?
As on Jul 01,2026, the Fundamentals of MARKOLINES PAVEMENT TECHNOLOGIES look Poor and hence it may not be good for long term investment ! See Financial Performance of MARKOLINES PAVEMENT TECHNOLOGIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is MARKOLINES PAVEMENT TECHNOLOGIES UnderValued or OverValued?
As on Jul 01,2026, MARKOLINES PAVEMENT TECHNOLOGIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of MARKOLINES PAVEMENT TECHNOLOGIES ?
As on Jul 01,2026, the Intrinsic Value of MARKOLINES PAVEMENT TECHNOLOGIES is Rs. 112.61 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 112.61
Fair Value [Median EV / Sales Model] : Rs. 97.56
Fair Value [Median Price / Sales Model] : Rs. 122.20
Estimated Median Fair Value of MARKOLINES PAVEMENT TECHNOLOGIES : Rs. 112.61
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.